Abstract:Background: Imaging of peritoneal malignancies using conventional cross-sectional imaging is challenging, but accurate assessment of peritoneal disease burden could guide better selection for definitive surgery. Here we demonstrate feasibility of high-resolution, high-contrast magnetic resonance imaging (MRI) of peritoneal mesothelioma and explore optimal timing for delayed post-contrast imaging. Methods: Prospective data from inpatients with malignant peritoneal mesothelioma (MPM), imaged with a novel MRI protocol, were analyzed. The new sequences augmenting the clinical protocol were (I) pre-contrast coronal high-resolution T2-weighted single-shot fast spin echo (COR hr T2w SSH FSE) of abdomen and pelvis; and (II) post-contrast coronal high-resolution three-dimensional (3D) T1-weighted modified Dixon (COR hr T1w mDIXON) of abdomen, acquired at five delay times, up to 20 min after administration of a double dose of contrast agent. Quantitative analysis of contrast enhancement was performed using linear regression applied to normalized signal in lesion regions of interest (ROIs). Qualitative analysis was performed by three blinded radiologists. Results: MRI exams from 14 participants (age: mean ± standard deviation, 60±12 years; 71% male) were analyzed. The rate of lesion contrast enhancement was strongly correlated with tumor grade (cumulative nuclear score) (r=-0.65, P<0.02), with 'early' delayed phase (12 min post-contrast) and 'late' delayed phase (19 min post-contrast) performing better for higher grade and lower grade tumors, respectively, in agreement with qualitative scoring of image contrast. Conclusions: High-resolution, high-contrast MRI with extended post-contrast imaging is a viable modality for imaging peritoneal mesothelioma. Multiple, extended (up to 20 min post-contrast) delayed phases are necessary for optimal imaging of peritoneal mesothelioma, depending on the grade of disease.

Old Borders and New Horizons in Multimodality Imaging of Malignant Pleural Mesothelioma

Imaging of Malignant Pleural Mesothelioma: Pearls and Pitfalls

Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group

Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma

Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group

Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group

Imaging evaluation of malignant pleural mesothelioma

Imaging Evaluation of Peritoneal Metastasis: Current and Promising Techniques

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors

Implementation of a high-resolution, high-contrast magnetic resonance imaging protocol with extended delayed phases for peritoneal mesothelioma

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients

Multimodality imaging review of metastatic melanoma involving the breast

Imaging of Peritoneal Surface Malignancies

Bi-Level Analysis of CT Images of Malignant Pleural Mesothelioma: Deep Learning-Based Classification and Subsequent 3D Reconstruction

Feasibility of Multimodal Multiphoton Microscopy to Facilitate Surgical Margin Assessment in Pancreatic Cancer.

Comments and Illustrations of the European Federation of Societies for Ultrasound in Medicine (EFSUMB) Guidelines: Rare Malignant Pulmonal and Pleural Tumors: Primary Pulmonary Sarcoma and Mesothelioma, Imaging Features on Transthoracic Ultrasound

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging

Multiparametric MRI for characterization of the tumour microenvironment

New Technologies for Human Cancer Imaging

Imaging in malignant peritoneal neoplasms